Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Airwheel Robot Cabin Suitcase Launched - World's First Full-Smart Luxury 20inch Electric Carry-on Hand Rideable AI Wheel LuggageBRUSSELS, BELGIUM, Sept 7, 2026 - Airwheel Unveils Next-Generation AI Suitcases with Electric Riding, Smart Connectivity and Cabin-Ready Design. As intelligent mobility and connected technology continue to reshape everyday life, the traditional suitcase is entering a new stage of evolution. Airwheel, a brand focused on intelligent mobility and smart travel solutions, is bringing electric drive systems, intelligent controls, connected functions and premium design into the luggage category, creating a new generation of AI Suitcase and Smart Suitcase products for modern travelers. For decades, innovation in luggage has largely focused on improving wheels, handles, materials and storage. Airwheel is taking a different approach by making the suitcase an active part of the journey. Through integrated electric mobility and intelligent control technologies, the brand is transforming luggage from something travelers simply pull into something that can actively move with them. From Pulling Luggage to Riding Suitcase Airwheel's intelligent luggage is built around a simple idea: technology should reduce effort rather than create additional complexity. By integrating electric drive systems into its luggage platform, Airwheel enables users to ride with their suitcases through airports, railway stations, hotels and other travel environments. This evolution from conventional luggage to a Rideable Suitcase is designed to make long walks, transfers and busy travel environments more manageable. The latest Airwheel SE3SXD takes this concept further with a one-touch riding system. With a simple press, the electric front wheel automatically deploys while the intelligent handle rises into position, allowing users to transition from pulling mode to riding mode with minimal effort. The riding speed can reach 9.9 km/h, while the retractable motorized front-wheel structure increases the wheelbase during riding to help improve stability and control across everyday surfaces, including indoor floors, sidewalks, speed bumps and moderate inclines. For Airwheel, the objective is not simply to create an Electric Suitcase that can be ridden, but to make intelligent mobility more intuitive and accessible in real-world travel scenarios. The Airwheel SE3SXD — A Flagship AI Luxury Suitcase Designed for Intelligent Travel As the flagship model in Airwheel's latest intelligent travel portfolio, the Airwheel SE3SXD brings together electric mobility, intelligent interaction, connected travel functions and premium luggage design in a single platform. The SE3SXD is designed around the idea that a modern suitcase should do more than carry belongings. Its one-touch riding system allows the electric front wheel to deploy automatically while the intelligent telescopic handle rises into position, creating a simplified transition from conventional luggage to rideable mobility. With a riding speed of up to 9.9 km/h, the SE3SXD is designed to help travelers move more efficiently through large airports, railway stations, hotels and urban environments. The retractable electric front-wheel structure extends the wheelbase during riding, helping provide a more stable riding experience while maintaining a compact profile when the suitcase is used in conventional pull mode. Its intelligent functions further distinguish the SE3SXD from traditional luggage. Through the dedicated Airwheel smart app, users can access riding-related controls and information, including speed adjustment, battery status, mileage, remote telescopic control and personalized lighting effects. Selected smart functions are designed to make the suitcase easier to monitor and customize according to different travel preferences. The SE3SXD also supports Apple Find My functionality, allowing compatible users to locate their suitcase through the Find My app. This adds a practical layer of connected luggage management, particularly in crowded airports, stations and other environments where keeping track of personal belongings can be challenging. Power management is another important part of the experience. The SE3SXD is equipped with a 73.26Wh removable lithium battery, with a modular design that allows the battery to be removed when required for transportation or security procedures. The suitcase body combines ABS+PC composite materials with a reinforced aviation-grade aluminum frame, providing structural support while maintaining a premium appearance. Together with its intelligent mobility system and connected functions, the SE3SXD represents Airwheel's vision of an AI Suitcase that combines practical technology with the expectations of premium travel. In this sense, the SE3SXD is not simply an Electric Suitcase or Rideable Suitcase. It brings together the functions of a Smart Suitcase, Cabin Suitcase and Luxury Suitcase, creating a more integrated approach to intelligent personal travel. Smart Connectivity Across the Travel Journey Electric riding is only one part of Airwheel's approach to smart luggage. Through the dedicated Airwheel smart app, compatible products support iOS, Android and HarmonyOS, enabling users to view key information such as riding speed, mileage and remaining battery power while customizing selected functions. Depending on the model, intelligent functions include variable speed adjustment, remote telescopic control, personalized lighting, low-battery alerts, distance alerts and intelligent cruise control. USB charging functionality further expands the role of Airwheel luggage. By providing a convenient charging interface, the suitcase can help travelers keep smartphones, tablets, wireless earbuds and other essential electronic devices powered throughout the journey. Together, these features transform the traditional suitcase into a more connected Smart Suitcase and Power Suitcase, designed around the increasingly digital nature of modern travel. A Product Portfolio Designed for Different Travel Needs Airwheel is expanding intelligent luggage across different sizes, users and travel scenarios rather than limiting the concept to a single suitcase format. Airwheel SE3SL+ Airport Suitcase and SE3SX Cabin Suitcase — Smart Cabin Mobility The SE3SL+ and SE3SX focus on the needs of frequent travelers seeking a balance between portability, riding functionality and cabin convenience. Designed around a 20-inch Cabin Suitcase format, the models combine electric riding capabilities with intelligent controls and connected functions. Their compact form makes them particularly suitable for travelers who regularly move between airports, railway stations, hotels and business destinations. With premium materials, integrated technology and rideable functionality, they also demonstrate how a Luxury Suitcase can evolve beyond appearance and storage to deliver practical intelligent mobility. Airwheel SE3T Electric Suitcase — Smart Luggage for Longer Journeys For travelers who need additional storage capacity, the Airwheel SE3T adopts a 24-inch format with approximately 48 liters of storage space. It retains the core riding concept while providing additional room for longer trips, family travel and journeys requiring more luggage. The SE3T demonstrates that smart mobility does not have to be limited to compact carry-on luggage. Airwheel SQ3 and SQ3S Kids suitcase — Intelligent Mobility for Family Travel Airwheel also extends its smart mobility concept to younger travelers with the SQ3 and SQ3S intelligent riding suitcases. Designed specifically for children, the models combine riding functionality with smart speaker features. With a maximum riding speed of up to 6.5 km/h and a maximum load of 40 kg, they bring entertainment and mobility together in a compact travel format. By expanding intelligent luggage into family travel, Airwheel is exploring how smart mobility can become part of the travel experience for different age groups. From compact cabin luggage to larger travel formats and family-oriented riding solutions, Airwheel's expanding product portfolio reflects a broader effort to bring intelligent mobility into different stages of the travel journey. Technology and Design Behind Intelligent Mobility A rideable suitcase requires more than an electric motor. It combines electric drive technology, battery management, structural engineering, intelligent controls and human-machine interaction within a compact luggage platform. Airwheel has built an intellectual property portfolio of more than 600 patents and 168 trademarks worldwide. Its products have received more than 39 international design awards, with recognition from design organizations and competitions in Germany, the United States, France, Berlin and Asia. The brand says its intelligent luggage products have also generated more than 20 billion media impressions worldwide, reflecting growing interest in the emerging category of smart and rideable travel products. From the Electric Suitcase to the connected Smart Suitcase, from the premium Cabin Suitcase to the emerging AI Suitcase, Airwheel is continuing to explore how technology can make travel more effortless. The vision is ultimately simple: when luggage becomes easier to move, easier to control and easier to track, travelers can spend less energy managing their belongings and more time enjoying the journey. Airwheel is redefining the role of luggage — from something travelers carry to an intelligent companion designed to move with them. Media Contact Company: Airwheel Contact: Media Team Email: [email protected] Website: https://www.airwheel.net
- BMW GroupFIA WEC: #15 BMW M Hybrid V8 finishes in the points at the Lone Star Le Mans in Austin.Companies: BMW+++ Challenging weekend for the BMW M Team WRT at the start of the second half of the FIA WEC season +++ #15 BMW M Hybrid V8 finishes eighth this time after the victory in São Paulo +++ The sister car misses out on the points, but Robin Frijns and René Rast maintain their lead in the drivers’ standings +++
- The Rosen Law Firm PACAR DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Against Pentwater Capital Management LP - CARWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the "Class Period"), of the important September 29, 2026 lead plaintiff deadline.SO WHAT: If you purchased Avis securities during the Class Period you may be entitled to...
- AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership with Macro HRD SG Pte. Ltd.AcroMeta to acquire a strategic stake in Macro-ATCLS Pte. Ltd., for the Ambient Temperature Cellular Logistics business. Option to acquire an exclusive licence to deploy the Ambient Temperature Cellular Logistics platform across Southeast Asia. The Group will continue to evaluate strategic opportunities that support its long-term growth. [L-R] Signing ceremony between Mr Toh Ker How, Executive Director of AcroMeta Group Limited, and Ms Kawinyarat Mardpiratchata, CFO and Managing Partner of Macro-HRD Pte. Ltd. SINGAPORE, Sept 7, 2026 - AcroMeta Group Limited (“AcroMeta”, or the “Company”, and together with its subsidiaries, the “Group”) today announced that it has entered into a non-binding term sheet (“Term Sheet”) with Macro HRD SG Pte. Ltd. (“Macro”), a Singapore-based provider of management consultancy services to the healthcare sector. The Term Sheet sets out the principal terms for a strategic partnership between AcroMeta and Macro-ATCLS Pte. Ltd. (“Macro-ATCLS”), the company through which Macro’s Ambient Temperature Cellular Logistics technology is being commercialised. Mr Lawrence Toh, Executive Director of AcroMeta Group Limited, said, “This proposed strategic partnership gives us the opportunity to build a position in an industry where cell and gene therapy logistics are expected to grow at double-digit rates in the years ahead. We see this as a natural extension of our strategy to grow our portfolio beyond our core operations, and we’re excited about the potential to build a meaningful presence in bringing this technology into Southeast Asia.” About Ambient Temperature Cellular Logistics (ATCLS) Ambient Temperature Cell Logistics (ATCLS) is an emerging technology licensed by Macro HRD, designed to fundamentally transform the transportation and distribution of living cells and other temperature-sensitive biological materials by eliminating reliance on conventional refrigerated and cryogenic cold chains. ATCLS uses proprietary ambient-temperature preservation and reactivation technologies, supported by its proprietary Gradient Equilibrium Decision Modeling (GEDM) platform for real-time governance, chain-of-identity and process control, enabling dormant living cells to be transported at ambient temperature and reactivated at the point of use. The opportunity addresses rapidly expanding markets including stem cells, CAR-T/immune-cell therapy, gene therapy, regenerative medicine, organ and tissue transplantation, and cell-and-gene-therapy logistics; the underlying markets cited in the project materials range from US$5.2 billion for immune-cell therapy to US$47 billion for organ transplantation, while the global cell-and-gene-therapy 3PL market is estimated at US$1.81 billion in 2025 and projected to reach US$16.95 billion by 2035 (25.1% CAGR). Based on defined ambient-addressable segments, ATCLS estimates a Serviceable Addressable Market (SAM) of approximately US$14.5 billion by 2032, positioning the technology as a potential category-creating solution capable of reducing the cost, fragility and geographic limitations of conventional cold-chain logistics. (See Footnote 1) Proposed Exclusive Licensing Arrangement for Southeast Asia AcroMeta will have an option to acquire an exclusive licence to deploy the ATCLS technology across agreed territories in Southeast Asia, including the right to appoint sub-licensees. The proposed exclusive licensing arrangement is intended to provide AcroMeta with the rights to develop and commercialise the ATCLS business within Southeast Asia. This structure allows AcroMeta to secure exclusive rights across the Southeast Asian markets, together with a first right to acquire additional territories, significantly expanding the Group’s potential commercial reach for the ATCLS technology. Building AcroMeta’s Platform Growth Strategy The Group intends to continue evaluating strategic opportunities to support its long-term value creation for shareholders. The Board remains focused on disciplined capital allocation as the Group progresses through its next phase of development. Footnote 1: This information was provided by Macro's management and has not been verified by the board of directors. The directors have not audited or verified the data supplied by the company. About AcroMeta Group Limited (SGX: 43F) AcroMeta Group Limited (“AcroMeta” or the “Company”, and together with its subsidiaries, the “Group”), is in the business of facility management services. The Company has been listed on the Catalist board of the Singapore Exchange since 2016. For more information, please visit www.AcroMeta.com. About Macro HRD SG Pte. Ltd. (Macro HRD) Macro HRD is a Singapore-based biotechnology and therapeutics company established in 2024, focused on developing scalable, precision-medicine solutions for high-burden infectious diseases with significant unmet medical needs. The company integrates advanced biology, therapeutic platform technologies and AI/ML-enabled decision systems to accelerate drug discovery and translational development from scientific research through clinical application. Its development portfolio includes innovative approaches targeting HIV/AIDS, HPV and other enveloped viruses, supported by proprietary therapeutic and drug-delivery platforms. Macro HRD brings together an international network of scientific, clinical, regulatory, investment and technology expertise, with the mission of translating breakthrough science into novel therapeutics with meaningful global healthcare impact. Media and Analysts Contact: Waterbrooks Consultants Pte Ltd Mr Wayne Koo Tel: +65 9338 8166 / +65 8901 9780 Email: [email protected] Email: [email protected]
- AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership with Macro HRD SG Pte. Ltd.AcroMeta to acquire a strategic stake in Macro-ATCLS Pte. Ltd., for the Ambient Temperature Cellular Logistics business. Option to acquire an exclusive licence to deploy the Ambient Temperature Cellular Logistics platform across Southeast Asia. The Group will continue to evaluate strategic opportunities that support its long-term growth. [L-R] Signing ceremony between Mr Toh Ker How, Executive Director of AcroMeta Group Limited, and Ms Kawinyarat Mardpiratchata, CFO and Managing Partner of Macro-HRD Pte. Ltd. SINGAPORE, Sept 7, 2026 - AcroMeta Group Limited (“AcroMeta”, or the “Company”, and together with its subsidiaries, the “Group”) today announced that it has entered into a non-binding term sheet (“Term Sheet”) with Macro HRD SG Pte. Ltd. (“Macro”), a Singapore-based provider of management consultancy services to the healthcare sector. The Term Sheet sets out the principal terms for a strategic partnership between AcroMeta and Macro-ATCLS Pte. Ltd. (“Macro-ATCLS”), the company through which Macro’s Ambient Temperature Cellular Logistics technology is being commercialised. Mr Lawrence Toh, Executive Director of AcroMeta Group Limited, said, “This proposed strategic partnership gives us the opportunity to build a position in an industry where cell and gene therapy logistics are expected to grow at double-digit rates in the years ahead. We see this as a natural extension of our strategy to grow our portfolio beyond our core operations, and we’re excited about the potential to build a meaningful presence in bringing this technology into Southeast Asia.” About Ambient Temperature Cellular Logistics (ATCLS) Ambient Temperature Cell Logistics (ATCLS) is an emerging technology licensed by Macro HRD, designed to fundamentally transform the transportation and distribution of living cells and other temperature-sensitive biological materials by eliminating reliance on conventional refrigerated and cryogenic cold chains. ATCLS uses proprietary ambient-temperature preservation and reactivation technologies, supported by its proprietary Gradient Equilibrium Decision Modeling (GEDM) platform for real-time governance, chain-of-identity and process control, enabling dormant living cells to be transported at ambient temperature and reactivated at the point of use. The opportunity addresses rapidly expanding markets including stem cells, CAR-T/immune-cell therapy, gene therapy, regenerative medicine, organ and tissue transplantation, and cell-and-gene-therapy logistics; the underlying markets cited in the project materials range from US$5.2 billion for immune-cell therapy to US$47 billion for organ transplantation, while the global cell-and-gene-therapy 3PL market is estimated at US$1.81 billion in 2025 and projected to reach US$16.95 billion by 2035 (25.1% CAGR). Based on defined ambient-addressable segments, ATCLS estimates a Serviceable Addressable Market (SAM) of approximately US$14.5 billion by 2032, positioning the technology as a potential category-creating solution capable of reducing the cost, fragility and geographic limitations of conventional cold-chain logistics. (See Footnote 1) Proposed Exclusive Licensing Arrangement for Southeast Asia AcroMeta will have an option to acquire an exclusive licence to deploy the ATCLS technology across agreed territories in Southeast Asia, including the right to appoint sub-licensees. The proposed exclusive licensing arrangement is intended to provide AcroMeta with the rights to develop and commercialise the ATCLS business within Southeast Asia. This structure allows AcroMeta to secure exclusive rights across the Southeast Asian markets, together with a first right to acquire additional territories, significantly expanding the Group’s potential commercial reach for the ATCLS technology. Building AcroMeta’s Platform Growth Strategy The Group intends to continue evaluating strategic opportunities to support its long-term value creation for shareholders. The Board remains focused on disciplined capital allocation as the Group progresses through its next phase of development. Footnote 1: This information was provided by Macro's management and has not been verified by the board of directors. The directors have not audited or verified the data supplied by the company. About AcroMeta Group Limited (SGX: 43F) AcroMeta Group Limited (“AcroMeta” or the “Company”, and together with its subsidiaries, the “Group”), is in the business of facility management services. The Company has been listed on the Catalist board of the Singapore Exchange since 2016. For more information, please visit www.AcroMeta.com. About Macro HRD SG Pte. Ltd. (Macro HRD) Macro HRD is a Singapore-based biotechnology and therapeutics company established in 2024, focused on developing scalable, precision-medicine solutions for high-burden infectious diseases with significant unmet medical needs. The company integrates advanced biology, therapeutic platform technologies and AI/ML-enabled decision systems to accelerate drug discovery and translational development from scientific research through clinical application. Its development portfolio includes innovative approaches targeting HIV/AIDS, HPV and other enveloped viruses, supported by proprietary therapeutic and drug-delivery platforms. Macro HRD brings together an international network of scientific, clinical, regulatory, investment and technology expertise, with the mission of translating breakthrough science into novel therapeutics with meaningful global healthcare impact. Media and Analysts Contact: Waterbrooks Consultants Pte Ltd Mr Wayne Koo Tel: +65 9338 8166 / +65 8901 9780 Email: [email protected] Email: [email protected]
- CAR DEADLINE NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Against Pentwater Capital Management LP - CARWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”), of the important September 29, 2026 lead plaintiff deadline.
- La Fédération dentaire internationale (FDI) lance « Generation Smile », un mouvement en faveur de la santé bucco-dentaire pour tous« Generation Smile » est une génération à part. Cela ne dépend pas de l'année de votre naissance. Elle rassemble des personnes de tous âges, de tous horizons et de toutes cultures autour d'un objectif commun : faire de la santé bucco-dentaire une priorité, car elle est essentielle à la...
- 受试者试药后死亡，知名生物公司董事怒怼记者：“滚开，烦不烦啊”，公司尚未有产品上市，正冲刺IPO原标题：受试者试药后死亡，知名生物公司董事怒怼记者：“滚开，烦不烦啊”，公司尚未有产品上市，正冲刺IPO，两年半亏损近3亿元 来源：中国经济网 近日，多家媒体报道称，一名男子在加入深圳易慕峰生物科技股份有限公司（以下称“易慕峰”）一项名为IMC002的CAR-T细胞临床试验后离世。 这起受试者死亡事件，恰逢易慕峰冲刺港股IPO的关键节点，将这家尚无产品上市的生物科技企业推向舆论风口。 然而，事件曝光后，易慕峰的对外沟通方式再添争议。在接受媒体采访时，该公司董事李佳昕却称“滚开，烦不烦啊。” 受试者注射试验药物后死亡 妻子质疑《知情同意书》没提示风险 9月4日，程女士告诉记者，其丈夫占某（化名，49岁）于2025年3月确诊胃食管结合部腺癌，随后在上海长海医院接受了全胃切除术及6次化疗。后续治疗整体平稳，身体状况良好。2026年初，在主治医生推荐下，占某加入了易慕峰开展的CAR-T细胞临床试验（药物代号IMC002）。 就在输注试验
- 特斯拉Robotaxi下月或实现全天候运营格隆汇9月6日｜特斯拉(Tesla)AI负责人埃卢斯瓦米(AshokElluswamy)表示，旗下自动驾驶的士(Robotaxi)全天候24小时服务即将落地。这标志着该公司的Robotaxi试点业务从仅限白天，转型为随需求随时提供的出行服务，覆盖此前一直无法提供服务的深夜时段。对于有网民希望特斯拉专为Robotaxi打造的Cybercab可以提供夜间出行服务，埃卢斯瓦米在社交平台回复称，待「v15...
- The Rosen Law Firm PACAR IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Against Pentwater Capital Management LP - CARWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the "Class Period"), of the important September 29, 2026 lead plaintiff deadline.SO WHAT: If you purchased Avis securities during the Class Period you may be entitled to...
- Roborock, 2026 yılının ilk yarısında %27,6'lık gelir artışı kaydetti ve küresel pazardaki liderliğini pekiştirdiBERLİN, 6 Eylül 2026 -- Günlük hayatı kolaylaştırmak üzere tasarlanmış ev robotik alanında dünya lideri olan Roborock, 2026 yılının ilk yarısında bir önceki yılın aynı dönemine göre %27,6 artışla 10,084 milyar RMB gelir elde etti; hissedarlara ait net kâr ise %45,6 artarak...
- 2026国谈第二日上午场：部分肿瘤药物开始谈判 合源生物、安斯泰来、恒瑞医药等中外企业代表入场格隆汇9月6日｜2026国谈第二日进程于8时左右开始，合源生物、远大医药、恒瑞医药、齐鲁制药、礼来、中国生物制药旗下正大天晴、石药集团、赛诺菲、信达生物、诺华等近20家国内外药企代表依次进场开始谈判。其中，合源生物的CAR-T药物纳基奥仑赛注射液于去年进入商保创新药目录，今年国谈申请进入基本医保目录并通过初审，还申请进行商保目录内适应症调整，预估上午谈判品种包含肿瘤治疗类药物。